Evidence map›Paper›PMID 37287410›Full record

ArticleBrain and behavior2023

Development of software for measuring brain amyloid accumulation using

Hiroshi Matsuda, Tsutomu Soma, Kyoji Okita, Yoko Shigemoto, Noriko Sato

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Quantification of global gray matter amyloid-β plaque fromAlzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hiroshi MatsudaDrug Discovery and Cyclotron Research Center, Southern Tohoku Research Institute for Neuroscience, Koriyama, Japan.ORCID 0000-0002-6297-9897
Tsutomu SomaSoftware Development Department, PDRadiopharma Inc., Tokyo, Japan.ORCID 0000-0001-9942-6463
Kyoji OkitaDepartment of Psychiatry, National Center of Neurology and Psychiatry, Kodaira, Japan.
Yoko ShigemotoDepartment of Radiology, National Center of Neurology and Psychiatry, Kodaira, Japan.
Noriko SatoDepartment of Radiology, National Center of Neurology and Psychiatry, Kodaira, Japan.
National Center of Neurology and Psychiatry · JPSoftware Research Associates (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeQuantitative measures have been proposed to aid the visual interpretation of amyloid PET. Our objective was to develop and validate quantitative software that enables calculation of the Centiloid (CL) scale and Z-score for amyloid PET with

methodsThis software was developed as a toolbox in statistical parametric mapping 12 running on MATLAB Runtime. For each participant's amyloid PET, this software calculates the CL scale using the standard MRI-guided pipeline proposed by the Global Alzheimer's Association Interactive Network (GAAIN) and generates a Z-score map for comparison with a new amyloid-negative database constructed from 20 healthy controls. In 23 cognitively impaired patients with suspected Alzheimer's disease, Z-score values for a target cortical area from the new database were compared with those from the GAAIN database constructed from 13 healthy controls. The CL values obtained using low-dose CT of PET/CT equipment were then compared with those obtained using MRI.

resultsThe CL calculation was validated with the

conclusionsOur quantification software provides the CL scale and Z-score for measuring overall and local amyloid accumulation with the use of MRI or low-dose CT.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAniline CompoundsBrainEthylene GlycolsHumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyAmyloid beta-PeptidesAniline CompoundsEthylene Glycolsflorbetapir18F-florbetapiramyloidCentiloid scalePET

Identifiers

PMID37287410
PMCPMC10338776
OpenAlexW4379768588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.